Observational studyThe Journal of international medical research2026
Safety evaluation of bleomycin in ovarian cancer treatment: A pharmacovigilance analysis using Food and Drug Administration adverse event reporting system data.
Xuan Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.